middle.news
CLINUVEL Boosts Singapore Hub to Lead Next-Gen Peptide Therapies
8:44am on Monday 8th of December, 2025 AEDT
•
Pharmaceuticals
Read Story
CLINUVEL Boosts Singapore Hub to Lead Next-Gen Peptide Therapies
8:44am on Monday 8th of December, 2025 AEDT
Key Points
Five-year expansion of VALLAURIX RD&I Centre in Singapore
Focus on developing long-acting liquid peptide drug formulations
Supported by Singapore Economic Development Board
Plans to increase specialist headcount without disrupting ongoing projects
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Clinuvel Pharmaceuticals (ASX:CUV)
OPEN ARTICLE